Loading organizations...
§ Private Profile · Guangzhou, Guangdong, China
Operates Traditional Chinese Medicine clinics and digital health platforms, offering herbal medicines and consultations.
Gushengtang Holdings operates a network of Traditional Chinese Medicine (TCM) clinics and healthcare facilities, integrating modern technology with traditional practices from its base in Guangzhou, Guangdong Province, China. The company offers clinical consultations, premium herbal medicines sourced through specialized supply chains, and digital health services via an OMO platform. This platform connects millions of patients with elite TCM physicians, while the company, operating under a Doctor-Partner model, employed approximately 2,915 to 3,546 individuals across over 80 institutions as of mid-2025. Gushengtang has been publicly traded on the Hong Kong Stock Exchange (HKEX: 2273) since December 2021, with key figures including Chairman and CEO Tu Zhiliang and CFO Shigang Deng. The organization was founded in 2010 by Tu Zhiliang and Zhan Jingsong.
Gushengtang Holdings has raised $224.4M across 2 funding rounds.
Gushengtang Holdings has raised $224.4M in total across 2 funding rounds.
Gushengtang Holdings has raised $224.4M across 2 funding rounds. Most recently, it raised $154.4M Debt / Series D in September 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 13, 2017 | $154.4M Debt Financing | — | China Life, China Merchants Bank, China National Capital, China Orient Asset Management (international) Holding Limited, Chongqing Finance Guidance Fund, Jinpu Medical, Xiaodong Jiang, Ping AN, Shanghai International Group, Shanghai Urban Investment, Shenzhen Innovation Investment Group | Announced |
| May 11, 2016 | $70M Venture Round | CV Starr | — | Announced |
Gushengtang Holdings has raised $224.4M in total across 2 funding rounds.
Gushengtang Holdings's investors include China Life, China Merchants Bank, China National Capital, China Orient Asset Management (International) Holding Limited, Chongqing Finance Guidance Fund, Jinpu Medical, Xiaodong Jiang, Ping An, Shanghai International Group, Shanghai Urban Investment, Shenzhen Innovation Investment Group, CV Starr.